WallStreetZenWallStreetZen

AnalystsAlan Carr
Alan Carr's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 21%
#946 out of 4527 analysts
Average Return
+16.98%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good

Alan Carr's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Moderna IncMRNA
+437.00%$29.16$156.59
2020-02-26 -
2020-12-09
Buy
Moderna IncMRNA
+194.40%$53.19$156.59
2020-05-07 -
2020-12-09
Buy
Crispr Therapeutics AgCRSP
+35.91%$86.40$117.43
2020-07-28 -
2021-07-27
Buy
Albireo Pharma IncALBO
+20.31%$27.33$32.88
2017-07-18 -
2018-07-18
Buy
Vertex Pharmaceuticals IncVRTX
+19.24%$133.50$159.19
2017-06-23 -
2018-06-22
Buy

Alan Carr Analyst Color

Get additional color on Alan Carr's coverage of popular stocks

Alan Carr's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Moderna IncMRNA
3HoldN/AN/ADowngrades
3 years ago
Vir Biotechnology IncVIR
1Buy$62.00N/AInitiates Coverage On
4 years ago
Crispr Therapeutics AgCRSP
1Buy$105.00N/AMaintains
4 years ago
Vaxcyte IncPCVX
1Buy$40.00N/AInitiates Coverage On
4 years ago
Intercept Pharmaceuticals IncICPT
3Buy$100.00N/AMaintains
4 years ago
Pliant Therapeutics IncPLRX
1Buy$40.00N/AInitiates Coverage On
4 years ago
Alnylam Pharmaceuticals IncALNY
2Buy$160.00N/AMaintains
4 years ago
Nabriva Therapeutics PLCNBRVF
2Buy$1,250.00N/AMaintains
4 years ago
Cidara Therapeutics IncCDTX
1Buy$6.00N/AMaintains
4 years ago
Iterum Therapeutics PLCITRM
1Buy$300.00N/AInitiates Coverage On
6 years ago
Arena Pharmaceuticals IncARNA
1BuyN/AN/AUpgrades
6 years ago
Genocea Biosciences IncGNCAQ
3BuyN/AN/AUpgrades
6 years ago
Albireo Pharma IncALBO
1Buy$35.00N/AInitiates Coverage On
7 years ago
Vertex Pharmaceuticals IncVRTX
1BuyN/AN/AUpgrades
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.